$CBUS: Cibus, Inc. - Class A Common Stock

Cibus, Inc. (CBUS) is a biotechnology company that develops and commercializes sustainable gene editing technologies for agriculture and food production. The company's leading product is the Cibus Precision Genome Editing (CPGE) platform, which allows for precise and targeted editing of plant genomes. CPGE has the potential to be used to develop a wide range of new crop varieties with improved traits, such as increased yields, resistance to pests and diseases, and tolerance to abiotic stresses.

Cibus is currently developing a pipeline of new crop varieties using CPGE, including high-yield wheat, drought-tolerant corn, and soybean varieties with improved nutritional value. The company also has a number of partnerships with leading seed and agricultural companies to develop and commercialize its CPGE technologies.

CBUS is a relatively young company, having been founded in 2001. However, the company has made significant progress in developing its CPGE technology and building a pipeline of new crop varieties. Cibus is well-positioned to take advantage of the growing demand for sustainable agricultural solutions.

Cibus is a pre-revenue company, so it is not yet profitable. However, the company has a strong cash position of over $100 million, which should give it enough runway to continue developing its CPGE technology and bringing new crop varieties to market.

Overall, Cibus is a biotechnology company with a promising future. The company's CPGE technology has the potential to revolutionize agriculture and food production. Cibus is well-positioned to take advantage of the growing demand for sustainable agricultural solutions.